Ignite Creation Date:
2024-05-06 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05133752
Status:
COMPLETED
Last Update Posted:
2021-11-24
First Post:
2021-11-08
Brief Title:
Oral Nemonoxacin in Treating Elderly Patients With CAP
Sponsor:
TaiGen Biotechnology Co Ltd
Organization:
TaiGen Biotechnology Co Ltd
Study Overview
Official Title:
A Multi-Center Open-Label Single-Arm Phase IV Study to Evaluate the Safety and Clinical Efficacy of Oral Administration With Nemonoxacin in Treating Elderly Patients With Community-Acquired Pneumonia
Status:
COMPLETED
Status Verified Date:
2021-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients aged 65 years with community-acquired pneumonia CAP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None